This month, Hoosier Cancer Research Network features Andrew S. Poklepovic, MD, in our investigator spotlight. Dr. Poklepovic serves as assistant professor in the Division of Hematology, Oncology and Palliative Care at the VCU Massey Cancer Center and is a Harrison Endowed Scholar at the VCU School of Medicine. He is also the medical director for the Massey Cancer Center Clinical Trials Office and an associate member of the Massey Cancer Center Developmental Therapeutics Program for the Department of Internal Medicine.

Dr. Poklepovic is a medical oncologist at Massey Cancer Center and practices at the Dalton Oncology Clinic and Stony Point Clinic. His research interests include melanoma, cutaneous oncology, squamous cell carcinoma, Merkel Cell Carcinoma, basal cell carcinoma, liver carcinoma, pancreatic cancer, breast cancer, and early phase clinical trials.

He has co-authored more than 80 peer-reviewed publications and is a member of HCRN’s Melanoma Clinical Trial Working Group. Dr. Poklepovic gave an inspiring TedxRVA talk several years ago that highlights how advances in cancer research have led to transformative change in treatment options and outcomes for patients.

Educational Background:

• Medical School: University of South Florida College of Medicine
• Residency: VCU Medical Center, Internal Medicine, Chief Resident
• Fellowship: VCU Medical Center, Hematology/Oncology

Three facts about Dr. Poklepovic:

• Avid mountain biker
• Chef
• Photographer

About Hoosier Cancer Research Network 

Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has conducted more than 230 trials in a variety of cancer types and supportive care, resulting in more than 350 publications. More than 9,000 subjects have participated in Hoosier Cancer Research Network clinical trials.